Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 - Biotechnology (Industry)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.82 USD | -0.80% | -19.26% | -42.72% |
May. 29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
May. 28 | Cytokinetics Closes $500 Million Stock Offering | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.72% | 5.49B | |
+8.38% | 114B | |
+10.13% | 104B | |
-11.69% | 22.5B | |
+1.66% | 22.57B | |
-11.18% | 17.95B | |
-41.90% | 16.48B | |
-16.00% | 15.82B | |
+2.28% | 13.55B | |
+20.54% | 10.99B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Cytokinetics, Incorporated(NasdaqGS: CYTK) added to S&P 400 - Biotechnology